NCT07714538

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-07-20Est. Completion: 2028-02-02

Enrollment target: 1,000 participants

Locations

Maidstone and Tunbridge Wells NHS Trust, Maidstone, Kent, United Kingdom
Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom
NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
Royal Free London NHS Foundation Trust, London, United Kingdom
Imperial College Healthcare NHS Trust, London, United Kingdom

Contact

Jessie S McClymont, Medical Biosciences BScbrave-study@imperial.ac.uk +44 7434937543

Other microbiome trials you might be interested in

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPhase 1Recruiting

Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid TumorUrinary Bladder NeoplasmTriple Negative Breast CancerNon-small Cell Lung CancerEsophageal CancerPancreatic CancerOvarian CancerCervical CancerHead and Neck Squamous Cell CarcinomaProstate CancerRenal Pelvis CancerBladder Cancer

The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in particip…

Duarte, United StatesEst. completion May 2027

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.